ATHN 9: Severe VWD Natural History Study



Status:Not yet recruiting
Healthy:No
Age Range:Any
Updated:3/6/2019
Start Date:March 2019
End Date:January 31, 2022
Contact:Hilary Markoe
Email:hsummermarkoe@athn.org
Phone:401-486-4615

Use our guide to learn which trials are right for you!

ATHN 9: A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People With Severe Von Willebrand Disease (VWD)

ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF)
regimens for different indications (on-demand, surgery and prophylaxis) in adult and
pediatric participants with clinically severe congenital VWD.

The overarching objective of this longitudinal, observational and prospective study is to
characterize the safety and effectiveness of factor replacement in participants with
clinically severe congenital VWD (VWF:Ag, VWF:GPlbM or VWF:RCo of ≤30% or ≤40% of normal with
severe bleeding phenotype defined as requiring recurrent use of factor concentrates) enrolled
in the ATHNdataset.

This is a longitudinal, observational cohort study being conducted at up to 30
ATHN-affiliated sites. Participants will be followed for 2 years from time of study
enrolment. The total study duration is 3 years.

Safety will be measured by the number of reported events defined by the European Haemophilia
Safety Surveillance (EUHASS) program. In addition, although not specifically defined by
EUHASS, treatment-emergent side effects of therapy will be included as reportable events
including: hypersensitivity/allergic reactions, thrombotic events, VW Factor inhibitor
development, treatment-emergent side effects of therapy, transfusion-transmitted infections,
malignancy, cardiovascular events, neurological events, unexpected poor efficacy and death.

Secondary objectives of ATHN 9 are:

- to enrich and analyze the data from currently enrolled participants with clinically
severe congenital VWD in the ATHNdataset via the collection of laboratory data
consisting of a standardized diagnostic battery using an ELISA based VWF activity assay,
and genetic sequence analysis of VWF coding regions and adjacent non-coding regions;

- to establish a platform for sub-studies for participants with congenital severe VWD,
that are treated with VWF products on demand or have started on or switched to a
particular VWF containing product for prophylaxis;

- to evaluate the use of factor replacement as prophylaxis in participants over 6-month
time periods;

- to describe bleeding events, changes in overall bleeding and annualized bleeding rate
(ABR) over the course of the study as measured by individual bleeding components; and

- to describe real-world effectiveness of VWD treatment as measured by health care
utilization and quality of life.

Inclusion Criteria:

1. Participants with severe Von Willebrand Disease with Type 3 VWD or VWF:RCo, VWF:GPlbM
or VWF:Ag ≤30% of pooled normal control plasma on more than one occasion;

2. Participants with clinically severe VWD as defined by VWF:RCo, VWF:GPlbM or VWF:Ag
≤40% of normal with severe bleeding phenotype defined as requiring recurrent use of
factor concentrates; and

3. Co-enrollment in the ATHNdataset.

Exclusion Criteria:

1. Diagnosis of platelet-type VWD;

2. Diagnosis of acquired VWD (clinical diagnosis based on association with
hypothyroidism, lymphoproliferative and myeloproliferative disorders, malignancies and
cardiovascular disease, typically aortic stenosis or LVAD).
We found this trial at
24
sites
Columbus, Ohio 43205
Principal Investigator: Amy Dunn, MD
?
mi
from
Columbus, OH
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
(615) 322-5000
Principal Investigator: Alexandra Borst, MD
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
?
mi
from
Nashville, TN
Click here to add this to my saved trials
Ann Arbor, Michigan 48109
Principal Investigator: Angela Weyand, MD
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Aurora, CO
Click here to add this to my saved trials
300 Longwood Avenue
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Cincinnati, Ohio 45229
Principal Investigator: Christina Tarango, MD
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
5 Richland Medical Park Dr
Columbia, South Carolina 29203
(803) 434-7000
Principal Investigator: Stuart Cramer, MD
Palmetto Health Richland Palmetto Health Richland, originally founded in 1892 as Columbia Hospital, has a...
?
mi
from
Columbia, SC
Click here to add this to my saved trials
Detroit, Michigan 48201
Principal Investigator: Madhvi Rajpurkar, MD
?
mi
from
Detroit, MI
Click here to add this to my saved trials
?
mi
from
East Lansing, MI
Click here to add this to my saved trials
Farmington, Connecticut 06030
Principal Investigator: Jonathan Bernstein, MD
Phone: 860-679-2100
?
mi
from
Farmington, CT
Click here to add this to my saved trials
Gainesville, Florida 32610
Principal Investigator: Tung Wynn, MD
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
Green Bay, Wisconsin 54311
Principal Investigator: Ken Friedman, MD
Phone: 920-965-0606
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
8326 Naab Road
Indianapolis, Indiana 46260
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Knoxville, Tennessee 37920
Principal Investigator: Wahid Hanna, MD
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
Milwaukee, Wisconsin 53233
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
1010 West La Veta Avenue
Orange, California 92868
Principal Investigator: Diane Nugent, MD
?
mi
from
Orange, CA
Click here to add this to my saved trials
?
mi
from
Peoria, IL
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Richmond, Virginia 23298
Principal Investigator: John C Barrett, MD
?
mi
from
Richmond, VA
Click here to add this to my saved trials
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Diego, California 92123
Principal Investigator: Courtney Thornburg, MD
?
mi
from
San Diego, CA
Click here to add this to my saved trials